OSENI - 64764-124-03 - (alogliptin and pioglitazone)

Alphabetical Index


Drug Information of OSENI

Product NDC: 64764-124
Proprietary Name: OSENI
Non Proprietary Name: alogliptin and pioglitazone
Active Ingredient(s): 12.5; 45    mg/1; mg/1 & nbsp;   alogliptin and pioglitazone
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED
Coding System: National Drug Codes(NDC)

Labeler Information of OSENI

Product NDC: 64764-124
Labeler Name: Takeda Pharmaceuticals America, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA022426
Marketing Category: NDA
Start Marketing Date: 20130125

Package Information of OSENI

Package NDC: 64764-124-03
Package Description: 30 TABLET, FILM COATED in 1 BOTTLE (64764-124-03)

NDC Information of OSENI

NDC Code 64764-124-03
Proprietary Name OSENI
Package Description 30 TABLET, FILM COATED in 1 BOTTLE (64764-124-03)
Product NDC 64764-124
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name alogliptin and pioglitazone
Dosage Form Name TABLET, FILM COATED
Route Name ORAL
Start Marketing Date 20130125
Marketing Category Name NDA
Labeler Name Takeda Pharmaceuticals America, Inc.
Substance Name ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE
Strength Number 12.5; 45
Strength Unit mg/1; mg/1
Pharmaceutical Classes Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator Receptor gamma Agonist [EPC],Peroxisome Proliferator-activated Receptor Activity [MoA],PPAR alpha [Chemical/Ingredient],PPAR gamma [Chemical/Ingredient],Thiazolidinedione [EPC],Thiazolidinediones [Chemical/Ingredient]

Complete Information of OSENI


General Information